New York State Common Retirement Fund Gilead Sciences, Inc. Transaction History

New York State Common Retirement Fund

  • $74.9 Billion
  • Q3 2025

A detailed history of New York State Common Retirement Fund transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 1,472,917 shares of GILD stock, worth $183 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
1,472,917
Previous 1,562,317 5.72%
Holding current value
$183 Million
Previous $173 Million 5.61%
% of portfolio
0.22%
Previous 0.24%

Shares

44 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 03, 2025
SELL
$108.22 - $120.47 $9.67 Million - $10.8 Million
-89,400 Reduced 5.72%
1,472,917 $163 Million
Q2 2025

Oct 08, 2025
SELL
$96.91 - $113.0 $1.46 Million - $1.71 Million
-15,100 Reduced 0.96%
1,562,317 $173 Million
Q2 2025

Aug 13, 2025
SELL
$96.91 - $113.0 $1.46 Million - $1.71 Million
-15,100 Reduced 0.96%
1,562,317 $173 Million
Q1 2025

Oct 08, 2025
SELL
$89.14 - $117.41 $4.87 Million - $6.42 Million
-54,671 Reduced 3.35%
1,577,417 $177 Million
Q1 2025

May 01, 2025
SELL
$89.14 - $117.41 $4.87 Million - $6.42 Million
-54,671 Reduced 3.35%
1,577,417 $177 Million
Q4 2024

Oct 08, 2025
SELL
$83.95 - $97.9 $6.76 Million - $7.88 Million
-80,477 Reduced 4.7%
1,632,088 $151 Million
Q4 2024

Jan 31, 2025
SELL
$83.95 - $97.9 $6.76 Million - $7.88 Million
-80,477 Reduced 4.7%
1,632,088 $151 Million
Q3 2024

Oct 08, 2025
BUY
$66.59 - $83.99 $10 Million - $12.6 Million
150,248 Added 9.62%
1,712,565 $144 Million
Q3 2024

Oct 28, 2024
SELL
$66.59 - $83.99 $16.4 Million - $20.6 Million
-245,800 Reduced 12.55%
1,712,565 $144 Million
Q2 2024

Oct 08, 2025
BUY
$63.15 - $72.88 $25 Million - $28.9 Million
396,048 Added 25.35%
1,958,365 $134 Million
Q2 2024

Jul 31, 2024
SELL
$63.15 - $72.88 $870,143 - $1 Million
-13,779 Reduced 0.7%
1,958,365 $134 Million
Q1 2024

Oct 08, 2025
BUY
$71.58 - $87.29 $29.3 Million - $35.8 Million
409,827 Added 26.23%
1,972,144 $144 Million
Q1 2024

May 07, 2024
SELL
$71.58 - $87.29 $5.73 Million - $6.99 Million
-80,057 Reduced 3.9%
1,972,144 $144 Million
Q4 2023

Oct 08, 2025
BUY
$73.27 - $83.09 $35.9 Million - $40.7 Million
489,884 Added 31.36%
2,052,201 $166 Million
Q4 2023

Feb 01, 2024
SELL
$73.27 - $83.09 $10.9 Million - $12.4 Million
-149,304 Reduced 6.78%
2,052,201 $166 Million
Q3 2023

Oct 08, 2025
BUY
$73.94 - $80.67 $47.3 Million - $51.6 Million
639,188 Added 40.91%
2,201,505 $165 Million
Q3 2023

Nov 07, 2023
SELL
$73.94 - $80.67 $4.66 Million - $5.08 Million
-63,011 Reduced 2.78%
2,201,505 $165 Million
Q2 2023

Oct 08, 2025
BUY
$76.01 - $86.7 $53.4 Million - $60.9 Million
702,199 Added 44.95%
2,264,516 $175 Million
Q2 2023

Aug 07, 2023
SELL
$76.01 - $86.7 $1.84 Million - $2.1 Million
-24,171 Reduced 1.06%
2,264,516 $175 Million
Q1 2023

Oct 08, 2025
SELL
$77.31 - $88.08 $8.33 Million - $9.49 Million
-107,694 Reduced 4.49%
2,288,687 $190 Million
Q1 2023

May 02, 2023
SELL
$77.31 - $88.08 $8.33 Million - $9.49 Million
-107,694 Reduced 4.49%
2,288,687 $190 Million
Q4 2022

Oct 08, 2025
BUY
$62.32 - $89.47 $52 Million - $74.6 Million
834,064 Added 53.39%
2,396,381 $206 Million
Q4 2022

Jan 30, 2023
BUY
$62.32 - $89.47 $2.69 Million - $3.86 Million
43,158 Added 1.83%
2,396,381 $206 Million
Q3 2022

Nov 08, 2022
SELL
$59.54 - $68.01 $6.72 Million - $7.67 Million
-112,812 Reduced 4.57%
2,353,223 $145 Million
Q2 2022

Aug 04, 2022
SELL
$57.72 - $65.01 $2.44 Million - $2.75 Million
-42,251 Reduced 1.68%
2,466,035 $152 Million
Q1 2022

May 05, 2022
BUY
$57.92 - $72.58 $190,440 - $238,643
3,288 Added 0.13%
2,508,286 $149 Million
Q4 2021

Feb 02, 2022
BUY
$64.88 - $73.64 $4.36 Million - $4.95 Million
67,209 Added 2.76%
2,504,998 $182 Million
Q3 2021

Nov 02, 2021
SELL
$67.69 - $73.03 $5.39 Million - $5.81 Million
-79,576 Reduced 3.16%
2,437,789 $170 Million
Q2 2021

Aug 02, 2021
SELL
$63.47 - $69.35 $4.05 Million - $4.42 Million
-63,773 Reduced 2.47%
2,517,365 $173 Million
Q1 2021

May 11, 2021
SELL
$60.0 - $68.46 $445,740 - $508,589
-7,429 Reduced 0.29%
2,581,138 $167 Million
Q4 2020

Feb 08, 2021
SELL
$56.65 - $64.55 $9.2 Million - $10.5 Million
-162,447 Reduced 5.9%
2,588,567 $151 Million
Q3 2020

Nov 05, 2020
SELL
$62.1 - $78.08 $8.91 Million - $11.2 Million
-143,488 Reduced 4.96%
2,751,014 $174 Million
Q2 2020

Aug 07, 2020
SELL
$72.34 - $84.0 $23.6 Million - $27.5 Million
-326,790 Reduced 10.14%
2,894,502 $223 Million
Q1 2020

May 06, 2020
SELL
$62.63 - $80.22 $9.44 Million - $12.1 Million
-150,689 Reduced 4.47%
3,221,292 $241 Million
Q4 2019

Feb 05, 2020
SELL
$61.62 - $67.78 $2.44 Million - $2.68 Million
-39,591 Reduced 1.16%
3,371,981 $219 Million
Q3 2019

Nov 07, 2019
SELL
$62.51 - $69.0 $2.6 Million - $2.87 Million
-41,576 Reduced 1.2%
3,411,572 $216 Million
Q2 2019

Aug 09, 2019
SELL
$61.87 - $69.38 $2.6 Million - $2.92 Million
-42,100 Reduced 1.2%
3,453,148 $233 Million
Q1 2019

May 08, 2019
BUY
$62.53 - $70.05 $231,361 - $259,185
3,700 Added 0.11%
3,495,248 $227 Million
Q4 2018

Feb 08, 2019
SELL
$60.54 - $79.0 $6.09 Million - $7.95 Million
-100,613 Reduced 2.8%
3,491,548 $218 Million
Q3 2018

Nov 07, 2018
SELL
$71.28 - $78.92 $3.56 Million - $3.95 Million
-50,000 Reduced 1.37%
3,592,161 $277 Million
Q2 2018

Aug 10, 2018
SELL
$64.88 - $75.68 $8.88 Million - $10.4 Million
-136,875 Reduced 3.62%
3,642,161 $258 Million
Q1 2018

May 10, 2018
SELL
$72.84 - $88.8 $3.05 Million - $3.71 Million
-41,817 Reduced 1.09%
3,779,036 $285 Million
Q3 2017

Nov 06, 2017
SELL
$72.11 - $85.47 $4.94 Million - $5.85 Million
-68,461 Reduced 1.76%
3,820,853 $310 Million
Q2 2017

Aug 11, 2017
BUY
N/A
3,889,314
3,889,314 $275 Million

Others Institutions Holding GILD

# of Institutions
2,370
Shares Held
1.01B
Call Options Held
8.63M
Put Options Held
7.39M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $156B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email